Kazuto Okimoto

1.2k total citations
19 papers, 1.0k citations indexed

About

Kazuto Okimoto is a scholar working on Pharmaceutical Science, Organic Chemistry and Pharmacology. According to data from OpenAlex, Kazuto Okimoto has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmaceutical Science, 4 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Kazuto Okimoto's work include Drug Solubulity and Delivery Systems (13 papers), Advanced Drug Delivery Systems (11 papers) and Oxidative Organic Chemistry Reactions (3 papers). Kazuto Okimoto is often cited by papers focused on Drug Solubulity and Delivery Systems (13 papers), Advanced Drug Delivery Systems (11 papers) and Oxidative Organic Chemistry Reactions (3 papers). Kazuto Okimoto collaborates with scholars based in Japan and United States. Kazuto Okimoto's co-authors include Rinta Ibuki, Roger A. Rajewski, Yuji Tokunaga, Kazutaka Higaki, Atsuo Ohike, Kaneto Uekama, Toshikiro Kimura, Toshiomi Nakate, Kazunari Yamashita and Valentino J. Stella and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Kazuto Okimoto

19 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuto Okimoto Japan 13 815 297 201 179 108 19 1.0k
Waseem Malick United States 13 735 0.9× 252 0.8× 151 0.8× 115 0.6× 155 1.4× 16 998
Akira Kusai Japan 17 602 0.7× 279 0.9× 137 0.7× 131 0.7× 117 1.1× 38 1.0k
Rinta Ibuki Japan 14 713 0.9× 244 0.8× 144 0.7× 99 0.6× 96 0.9× 25 960
K. P. R. Chowdary India 16 844 1.0× 233 0.8× 206 1.0× 148 0.8× 120 1.1× 83 1.1k
Bhaskar Chauhan India 14 595 0.7× 239 0.8× 129 0.6× 129 0.7× 121 1.1× 22 874
Sunil S. Jambhekar United States 13 576 0.7× 207 0.7× 159 0.8× 155 0.9× 193 1.8× 21 1.0k
Martin H. Infeld United States 16 851 1.0× 153 0.5× 203 1.0× 117 0.7× 168 1.6× 29 1.1k
Yatindra M. Joshi United States 16 879 1.1× 432 1.5× 219 1.1× 249 1.4× 217 2.0× 18 1.2k
Giovanna Corti Italy 15 578 0.7× 146 0.5× 122 0.6× 125 0.7× 109 1.0× 15 786
Sibeum Lee South Korea 13 667 0.8× 282 0.9× 166 0.8× 231 1.3× 107 1.0× 18 1.0k

Countries citing papers authored by Kazuto Okimoto

Since Specialization
Citations

This map shows the geographic impact of Kazuto Okimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuto Okimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuto Okimoto more than expected).

Fields of papers citing papers by Kazuto Okimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuto Okimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuto Okimoto. The network helps show where Kazuto Okimoto may publish in the future.

Co-authorship network of co-authors of Kazuto Okimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuto Okimoto. A scholar is included among the top collaborators of Kazuto Okimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuto Okimoto. Kazuto Okimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Okimoto, Kazuto, et al.. (2021). Preparation of Novel Functional Drug Particles Embedded in a Gelling–Swelling Layer (PEGS) for Taste Masking and Subsequent Rapid Drug Release. Chemical and Pharmaceutical Bulletin. 69(4). 383–390. 5 indexed citations
2.
Okimoto, Kazuto, et al.. (2021). Preparation of Solifenacin Succinate Functional Particles Embedded in a Gelling–Swelling Layer (PEGS) and Their Formulation in Orally Disintegrating Tablets. Chemical and Pharmaceutical Bulletin. 69(5). 456–463. 1 indexed citations
3.
Okimoto, Kazuto, et al.. (2014). Formulation Design for Orally Disintegrating Tablets Containing Enteric-Coated Particles. Chemical and Pharmaceutical Bulletin. 62(5). 407–414. 11 indexed citations
4.
Okimoto, Kazuto, et al.. (2011). Further improvement of orally disintegrating tablets using micronized ethylcellulose. International Journal of Pharmaceutics. 423(2). 351–359. 22 indexed citations
5.
Okimoto, Kazuto, et al.. (2009). A new formulation for orally disintegrating tablets using a suspension spray-coating method. International Journal of Pharmaceutics. 382(1-2). 80–87. 51 indexed citations
6.
Tanaka, Nobuyuki, Keiji Imai, Kazuto Okimoto, et al.. (2006). Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation. Journal of Controlled Release. 112(1). 51–56. 76 indexed citations
7.
Tanaka, Nobuyuki, Keiji Imai, Kazuto Okimoto, et al.. (2005). Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. Journal of Controlled Release. 108(2-3). 386–395. 59 indexed citations
8.
Okimoto, Kazuto, Yuji Tokunaga, Rinta Ibuki, et al.. (2004). Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs). International Journal of Pharmaceutics. 286(1-2). 81–88. 43 indexed citations
9.
Yamashita, Kazunari, Toshiomi Nakate, Kazuto Okimoto, et al.. (2003). Establishment of new preparation method for solid dispersion formulation of tacrolimus. International Journal of Pharmaceutics. 267(1-2). 79–91. 295 indexed citations
10.
Hirayama, Fumitoshi, et al.. (2000). X-ray crystallographic characterization of nilvadipine monohydrate and its phase transition behavior. European Journal of Pharmaceutical Sciences. 11(1). 81–88. 37 indexed citations
11.
Okimoto, Kazuto, Atsuo Ohike, Rinta Ibuki, et al.. (1999). Design and Evaluation of an Osmotic Pump Tablet (OPT) for Chlorpromazine Using (SBE)7m-β-CD. Pharmaceutical Research. 16(4). 549–554. 36 indexed citations
12.
Okimoto, Kazuto, Roger A. Rajewski, & Valentino J. Stella. (1999). Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-β-cyclodextrin as both a solubilizing and an osmotic pump agent. Journal of Controlled Release. 58(1). 29–38. 62 indexed citations
13.
Okimoto, Kazuto, Atsuo Ohike, Rinta Ibuki, et al.. (1999). Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)7m-β-CD as both a solubilizer and osmotic agent. Journal of Controlled Release. 60(2-3). 311–319. 38 indexed citations
14.
Okimoto, Kazuto, Norio Ohnishi, Roger A. Rajewski, et al.. (1998). Design and Evaluation of an Osmotic Pump Tablet (OPT) for Prednisolone, a Poorly Water Soluble Drug, Using (SBE)7m-β-CD. Pharmaceutical Research. 15(10). 1562–1568. 57 indexed citations
15.
Okimoto, Kazuto, et al.. (1997). Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose. International Journal of Pharmaceutics. 159(1). 85–93. 78 indexed citations
16.
Okimoto, Kazuto, Roger A. Rajewski, Kaneto Uekama, Janan Jona, & Valentino J. Stella. (1996). The Interaction of Charged and Uncharged Drugs with Neutral (HP-β-CD) and Anionically Charged (SBE7-β-CD) β-Cyclodextrins. Pharmaceutical Research. 13(2). 256–264. 133 indexed citations
19.
Kobayashi, Shigeru, Kazuto Okimoto, & Yasuhiro Imakura. (1982). Cleavage of the methylenedioxy ring. III. Cleavage with sodium benzyloxide in dimethyl sulfoxide.. Chemical and Pharmaceutical Bulletin. 30(5). 1567–1573. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026